Faculty Profile

Dag Morten Dalen

Professor - Research and Academic Resources

Department of Economics

Biography

I am a professor of economics at BI Norwegian Business School. My current research interests are industrial organization and economics of strategy, pharmaceutical markets and public regulation of utilities and industries.

I served as provost of BI Norwegian Business School for 8 years (2010-2018).

See my personal homepage for more information: dmdalen.com

Area of Expertise

Publications

Dalen, Dag Morten; Locatelli, Marilena & Strøm, Steinar Øivind (2018)

An Equilibrium Model Estimated on Pharmaceutical Data

Atlantic Economic Journal, 46(3), s. 281- 296. Doi: 10.1007/s11293-018-9592-8 - Full text in research archive

The purpose of this paper is to estimate patients’ and doctors’ responses to prices when making a choice between brand name products and generics. We account for the response of pharmacies to government regulation and to prices set by brand name producers. The data from the Norwegian Prescription Database are unique in the sense that we observe prices set by pharmacies as well as by producers. Our results confirm that estimating only the demand side yields biased estimates of consumers’ price responses. We find much stronger price responses when demand and supply are jointly estimated.

Dalen, Dag Morten; Locatelli, Marilena, Sorisio, Enrico & Strøm, Steinar (2014)

Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?

Applied Economics and Finance, 1(1) Doi: 10.11114/aef.v1i1.324

Brekke, Kurt; Dalen, Dag Morten & Holmås, Tor Helge (2014)

Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs

European Journal of Health Economics, 15(9), s. 937- 951. Doi: 10.1007/s10198-013-0536-6 - Full text in research archive

This article studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries covering the period from the first launch in 2000 until becoming blockbusters in 2009. Descriptive statistics reveal large variations across countries in per-capita consumption and price levels both overall and at the brand level. We explore potential sources for the cross-country consumption differences by estimating several multivariate regression models. Our results show that large parts of the cross-country variation are explained by time-invariant country-specific factors (e.g., disease prevalence, demographics, health care system). We also find that differences in income [gross domestic product (GDP) per capita] and health spending (share of GDP) explain the cross-country variation in consumption, while relative price differences seem to have limited impact.

Dalen, Dag Morten & Moen, Espen R (2012)

Ownership and Cost-Sharing Contracts

Australian Economic Papers, 51(3), s. 134- 146. Doi: 10.1111/j.1467-8454.2012.00428.x

Brekke, Kurt; Dalen, Dag Morten & Strøm, Steinar (2012)

Should pharmaceutical costs be curbed?

Nordic Economic Policy Review, 2, s. 1- 27.

Pharmaceuticals account for almost a fifth of total health spending in OECD-countries. Both pharmaceutical innovations and the aging of the population explain the increasing importance of pharmaceuticals in health care. Due to the importance of patent protection and insurance coverage, pharmaceutical markets are subjected to economic regulation – both on the supply-side and the demand-side. In this paper, we briefly review the Nordic pharmaceutical market, before explaining the main regulatory policy measures taken by governments in these countries. Empirical re-search has been undertaken to investigate regulation and competition, and we provide a review of some of the findings.

Dalen, Dag Morten; Hoel, Michael Olaf & Strøm, Steinar (2011)

Markedsmakt og innovasjon på norsk sokkel

Samfunnsøkonomen, 65(3), s. 40- 45.

Dalen, Dag Morten; Furu, Kari, Locatelli, Marilena & Strøm, Steinar (2011)

Generic substitution: micro evidence from register data in Norway

European Journal of Health Economics, 12(1), s. 49- 59. Doi: 10.1007/s10198-010-0226-6

Dalen, Dag Morten; Hoel, Michael & Strøm, Steinar (2008)

Kalkulasjonsrenten på lang sikt i en usikker verden

Samfunnsøkonomen

Dalen, Dag Morten & Strøm, Steinar (2006)

The pharmaceutical market in Norway

Competition and Welfare: The Norwegian Experience, ed. Lars Sørgard

Dalen, Dag Morten; Strøm, Steinar & Haabeth, Tonje (2006)

Price regulation and generic competition in the pharmaceutical market

European Journal of Health Economics, 7, s. 208- 214.

Dalen, Dag Morten; Moen, Espen R. & Riis, Christian (2006)

Contract renewal and incentives in public procurement

International Journal of Industrial Organization, 24(2), s. 269- 285.

This paper explores how the government's choice of renewal policy in public procurement programs can be used as a mechanism to provide firms with incentives to supply quality. A public service is produced by several firms. The firms participate in a tournament where they are ranked according to the quality of their services, and rewarded in terms of contract renewals. We analyse the firms' incentives to produce high-quality services, and find that they are maximised if 50% of the contracts are renewed. The optimal renewal policy trades off incentive provision (which requires that a relatively large fraction of the firms are replaced each period) against the entry costs of new firms. (c) 2005 Elsevier B.V. All rights reserved.

Dalen, Dag Morten & Gomez-Lobo, Andres (2003)

Yardsticks on the road: Regulatory contracts and cost efficiency in the Norwegian Bus Industry

Transportation, 30, s. 371- 368.

Dalen, Dag Morten; Fehr, Nils-H. M. Von der & Moen, Espen R. (2003)

Regulation with Wage Bargaining

Economic Journal, 113(487), s. 525- 538.

Dalen, Dag Morten (2001)

Reformer i helsesektoren - politikk og økonomisk realiteter

?

Dalen, Dag Morten & Lund, Arild J. (2001)

Håndtering av finansielle kriser: Norges banks rolle

Økonomisk forum, 55(3), s. 12- 17.

Dalen, Dag Morten; Moen, Espen R. & Riis, Christian (2001)

Public Ownership as a Signalling Device

Nordic Journal of Political Economy, 27(1), s. 3- 12.

Dalen, Dag Morten (2000)

Regulering og internasjonal regelverkskonkurranse

NOU 2000:9 Konkurranseflater i finansnæringen

Dalen, Dag Morten (2000)

Konkurranseutsetting av offentlige tjenester

Sosialøkonomen, 54(7), s. 23- 28.

Dalen, Dag Morten (2000)

Catching-up investemnet without regulatory commitment

Journal of Regulatory Economics, 18, s. 133- 150.

Dalen, Dag Morten (1998)

Yardstick competition and investment incentives

?

Brekke, Kurt; Dalen, Dag Morten & Holmås, Tor Helge (2013)

Diffusion of Pharmaceuticals: Cross-Country Evidence of Anti-TNF drugs

[Report]. Department of Economics, Norwegian School of Economics.

This paper studies the di¤usion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries covering the period from the fi…rst launch in 2000 until becoming blockbusters in 2009. Descriptive statistics reveal large variations across countries in per-capita consumption and price levels both overall and at brand level. We explore potential sources for the cross-country consumption differences by estimating several multivariate regression models. Our results show that large parts of the cross-country variation are explained by time-invariant country-speci…c factors (e.g., disease prevalence, demographics, health care system). We also fi…nd that differences in income (GDP per capita) and health spending (share of GDP) explain the cross-country variation in consumption, while relative price differences seem to have limited impact.

Strøm, Steinar; Hoel, Michael Olaf & Dalen, Dag Morten (2012)

Verdsetting av økosystemtjenester

[Report]. Vista Analyse AS.

Hoel, Michael Olaf; Strøm, Steinar & Dalen, Dag Morten (2012)

Tariffering og bruk av gassinfrastruktur

[Report]. Vista Analyse AS.

Dalen, Dag Morten & Riis, Christian (2010)

Konkurranse for innovasjon

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten; Moen, Espen R & Riis, Christian (2010)

Regulering av fjernvarme

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten & Moen, Espen R (2010)

Borgerlønn:en samfunnsøkonomisk analyse

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten; Sorisio, Enrico & Strøm, S. (2009)

Choosing among Competing Blockbusters: Does the Identity of the Third‐party Payer Matter for Prescribing Doctors?

[Report]. Department of Economics. University of Oslo.

Dalen, Dag Morten & van Dijk, Theo H. (2009)

Imperfect enforcement of predatory pricing law

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten (2009)

Private enforcement of predatory pricing law

[Academic lecture]. The Fourth International Conference on Competition and Regulation (CRESSE.

Dalen, Dag Morten (2009)

Reimbursement policy and physicians’ choice of biopharmaceuticals: The case of TNF-alpha inhibitors

[Academic lecture]. Helseøkonomikonferansen.

Dalen, Dag Morten (2009)

Sykehusenes legemiddelanbud. Konkurranse på hvilke vilkår?

[Article in business/trade/industry journal]. Samfunnsøkonomen

Dalen, Dag Morten & Grammeltvedt, Thor-Erik (2008)

The efficient public owner of a public utility: Too many to be true?

[Academic lecture]. EEA ESEM 2008.

Dalen, Dag Morten; Moen, Espen R. & Riis, Christian (2007)

Regulering av fjernvarme: Utredning for Olje- og energidepartementet

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten; Strøm, Steinar & Haabeth, Tonje (2005)

Price regulation and generic competition in the pharmaceutical market

[Report]. Universitetet i Oslo.

Bjørnenak, Trond; Dalen, Dag Morten, Dalen, Dag Morten, Fehr, Nils-H. M. Von der, Olsen, Trond E. & Torsvik, Gaute (2005)

På like vilkår? Analyse av konkurranse mellom offentlige og private foretak

[Non-fiction book]. Konkurransetilsynet.

Dalen, Dag Morten; Lædre, Ola & Riis, Christian (2004)

Statlig styring av prosjektledelse

[Report]. Frischsenteret.

Dalen, Dag Morten & Strøm, S. (2004)

Pris- og avanseregulering for legemidler

[Report]. Frischsenteret.

Moen, Espen R.; Dalen, Dag Morten & Riis, Christian (2003)

Privat arbeidsformidling

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten & Gomez-Lobo, Andres (2002)

Regulatory contracts and cost efficiency in the Norwegian Bus Industry: Do high-powered contracts really work?

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten; Grytten, Jostein & Sørensen, Rune J. (2002)

Mer penger eller mer for pengene? Organisering og finansiering av norske sykehus

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten (2002)

Kan konkurranse bidra til lavere legemiddelpriser?En evaluering av myndighetenes prisregulering

[Report]. Handelshøyskolen BI.

Dalen, Dag Morten; Dalen, Dag Morten & Olsen, Trond E. (2002)

Strategic regulation of a multi-national banking industry

[Report]. Institutt for foretaksøkonomi. Norges handelshøyskole.

This paper focuses on the consequences of cross-border banking and entry of multi-national bank (MNB) subsidiaries for banking supervision and regulation. When a MNB expands internationally with subsidiaries, the MNB operates under the legislation of several countries - both the home country and the host countries. Although these countries have agreed upon minimum standards and supervisory principles, such as in the EU directives or the Basle Accords, substantial degrees of freedom are still left to the national regulators. An interesting and important issue is whether the decentralized approach to regulation of MNBs creates inefficiencies and financial instability. Host country regulation of MNB subsidiaries creates cross-border externalities, where the supervisors and regulators in one country will be concerned with the standards in the home country and in other host countries. Our main result is that lack of international coordination of banking regulation works to lower capital adequacy requirements. In equilibrium, however, regulators respond by increasing the incentives to improve asset quality, making the probability of banking failure insensitive to the decentralized nature of banking regulation. Ownership of the MNB is shown to be of importance for the outcome of strategic banking regulation.

Sørensen, Rune J. & Dalen, Dag Morten (2001)

Eierskap og tilknytningsformer i offentlig sektor. En diskusjon av teori og empiriske resultater i internasjonal forskning

[Report]. Handelshøyskolen BI.

Academic Degrees
Year Academic Department Degree
1996 University of Oslo Ph.D Dr. Polit.
1991 University of Oslo Master Cand. Oecon
Work Experience
Year Employer Job Title
2004 - Present BI Norwegian Business School Professor
2010 - 2018 BI Norwegian Business School Provost - Senior Vice President
2006 - 2010 BI Norwegian Business School Associate Dean, MSc in Business and Economics
2006 - 2007 BI Norwegian Business School Acting Head of Department
1998 - 2004 BI Norwegian Business School Associate Professor
1999 - 2000 Central Bank of Norway Senior advisor (part time)
1997 - 1998 Stortinget (The Norwegian Parliament) Advisor
1996 - 1998 SNF-Oslo Researcher
1992 - 1996 University of Oslo, Dept. of Economics Research fellow